Genpharmasec Limited (BOM:531592)

India · Delayed Price · Currency is INR

0.8400

-0.0700 (-7.69%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Laboratory Testing	11.63M	-	-	-	-
Pharmaceuticals	325.56M	304.06M	252.83M	266.11M	207.99M
Pharmaceuticals Growth	7.07%	20.26%	-4.99%	27.94%	26.05%
Trading in Securities	30.00K	-	2.32M	7.09M	5.08M
Trading in Securities Growth	-	-	-67.25%	39.57%	-
Total	337.22M	304.06M	255.16M	273.21M	213.08M
Total Growth	10.91%	19.16%	-6.61%	28.22%	29.13%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	337.22M	304.06M	255.16M	273.21M	213.08M
India Growth	10.91%	19.16%	-6.61%	28.22%	29.13%
Total	337.22M	304.06M	255.16M	273.21M	213.08M
Total Growth	10.91%	19.16%	-6.61%	28.22%	29.13%

Source: S&P Global Market Intelligence.